GlassScriptPhysician profile
Julia C Sass
NPI 1003539784
$2,182.17
in general payments reported to CMS, 2019-2025
18 companies · $584 in 2025
The $584 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $59.70 · 2023: $926 · 2024: $613 · 2025: $584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,916 · Education: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,915.64 |
| Education | $206.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $512.58 | 2023-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $302.95 | 2023-2025 | Abilify Asimtufii, Rexulti, Abilify Maintena |
| Abbvie INC. | $268.31 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $256.04 | 2023-2025 | Uzedy, Austedo Xr |
| Axsome Therapeutics, INC. | $157.12 | 2023-2025 | Auvelity |
| Alkermes, INC. | $117.24 | 2022-2025 | Aristada, Lybalvi, Vivitrol |
| Lundbeck LLC | $93.35 | 2023-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $77.26 | 2023-2024 | Invega Sustenna |
| Corium, LLC | $75.33 | 2023-2024 | Azstarys |
| Indivior INC. | $72.00 | 2023-2024 | Perseris |
| Collegium Pharmaceutical, INC. | $56.73 | 2025 | Jornay Pm |
| Vanda Pharmaceuticals INC. | $39.62 | 2025 | Fanapt |
| Neurocrine Biosciences, INC. | $38.80 | 2023-2025 | Ingrezza |
| Merck Sharp & Dohme LLC | $31.28 | 2023 | Belsomra |
| Bayer Healthcare Pharmaceuticals INC. | $26.11 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $23.30 | 2024 | |
| Almatica Pharma LLC | $20.29 | 2024 | Loreev Xr |
| Idorsia Pharmaceuticals US INC | $13.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Sass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.